Astellas Pharma, Inc. (ALPMY)
15.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Astellas Pharma EPS Diluted (Quarterly) : 0.4955 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4955 |
| March 31, 2026 | 0.1543 |
| December 31, 2025 | 0.3625 |
| September 30, 2025 | 0.2989 |
| June 30, 2025 | 0.2636 |
| March 31, 2025 | 0.2738 |
| December 31, 2024 | -0.358 |
| September 30, 2024 | 0.1338 |
| June 30, 2024 | 0.1344 |
| March 31, 2024 | -0.125 |
| December 31, 2023 | 0.0545 |
| September 30, 2023 | -0.0056 |
| June 30, 2023 | 0.1339 |
| March 31, 2023 | -0.1925 |
| December 31, 2022 | 0.1877 |
| September 30, 2022 | 0.284 |
| June 30, 2022 | 0.1047 |
| March 31, 2022 | -0.0393 |
| December 31, 2021 | 0.2888 |
| September 30, 2021 | 0.2005 |
| June 30, 2021 | 0.1513 |
| March 31, 2021 | -0.0626 |
| December 31, 2020 | 0.3094 |
| September 30, 2020 | 0.1137 |
| June 30, 2020 | 0.2523 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0266 |
| December 31, 2019 | 0.3015 |
| September 30, 2019 | 0.3456 |
| June 30, 2019 | 0.2821 |
| March 31, 2019 | 0.1467 |
| December 31, 2018 | 0.4043 |
| September 30, 2018 | 0.2285 |
| June 30, 2018 | 0.2533 |
| March 31, 2018 | 0.1021 |
| December 31, 2017 | 0.2655 |
| September 30, 2017 | 0.1746 |
| June 30, 2017 | 0.1848 |
| March 31, 2017 | 0.1699 |
| December 31, 2016 | 0.2758 |
| September 30, 2016 | 0.2225 |
| June 30, 2016 | 0.2901 |
| March 31, 2016 | 0.1187 |
| December 31, 2015 | 0.2359 |
| September 30, 2015 | 0.2213 |
| June 30, 2015 | 0.1669 |
| March 31, 2015 | 0.0806 |
| December 31, 2014 | 0.1733 |
| September 30, 2014 | 0.1464 |
| June 30, 2014 | 0.1586 |
| December 31, 2013 | 0.1454 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Ono Pharmaceutical Co., Ltd. | 0.1075 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 889.54M |
| Revenue (Quarterly) | 4.022B |
| Total Expenses (Quarterly) | 3.133B |
| Enterprise Value | 29.10B |
| Gross Profit Margin (Quarterly) | 75.29% |
| Profit Margin (Quarterly) | 22.12% |
| Earnings Yield | 8.72% |
| Operating Earnings Yield | 11.84% |
| Normalized Earnings Yield | 8.717 |